0001415889-24-026758.txt : 20241113 0001415889-24-026758.hdr.sgml : 20241113 20241113194302 ACCESSION NUMBER: 0001415889-24-026758 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241111 FILED AS OF DATE: 20241113 DATE AS OF CHANGE: 20241113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thompson Travis Alvin CENTRAL INDEX KEY: 0001983944 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38916 FILM NUMBER: 241456388 MAIL ADDRESS: STREET 1: C/O BICYCLE THERAPEUTICS PLC STREET 2: BLOCKS A & B, PORTWAY BUILDING CITY: CAMBRIDGE STATE: X0 ZIP: CB21 6GS ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS PLC CENTRAL INDEX KEY: 0001761612 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BLOCKS A & B, PORTWAY BUILDING STREET 2: GRANTA PARK, GREAT ABINGTON CITY: CAMBRIDGE STATE: X0 ZIP: CB21 6GS BUSINESS PHONE: 011441223261503 MAIL ADDRESS: STREET 1: BLOCKS A & B, PORTWAY BUILDING STREET 2: GRANTA PARK, GREAT ABINGTON CITY: CAMBRIDGE STATE: X0 ZIP: CB21 6GS FORMER COMPANY: FORMER CONFORMED NAME: BICYCLE THERAPEUTICS plc DATE OF NAME CHANGE: 20190530 FORMER COMPANY: FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd DATE OF NAME CHANGE: 20181212 4 1 form4-11142024_121158.xml X0508 4 2024-11-11 0001761612 BICYCLE THERAPEUTICS PLC BCYC 0001983944 Thompson Travis Alvin C/O BICYCLE THERAPEUTICS PLC BLOCKS A & B, PORTWAY BUILDING CAMBRIDGE X0 CB21 6GS UNITED KINGDOM false true false false CHIEF ACCOUNTING OFFICER 1 Ordinary Shares 2024-11-11 4 M 0 1312 1.87 A 24234 D Ordinary Shares 2024-11-11 4 S 0 1312 25.05 D 22922 D Ordinary Shares 2024-11-11 4 M 0 154 8.21 A 23076 D Ordinary Shares 2024-11-11 4 S 0 154 25.01 D 22922 D Ordinary Shares 2024-11-11 4 M 0 1109 9.82 A 24031 D Ordinary Shares 2024-11-11 4 S 0 1109 25.05 D 22922 D Ordinary Shares 2024-11-11 4 S 0 3241 25.21 D 19681 D Ordinary Shares 2024-11-11 4 S 0 209 24.77 D 19472 D Ordinary Shares 2024-11-11 4 S 0 231 24.82 D 19241 D Employee Stock Option (right to buy) 1.87 2024-11-11 4 M 0 1312 0 D 2028-09-17 Ordinary Shares 1312 2617 D Employee Stock Option (right to buy) 8.21 2024-11-11 4 M 0 154 0 D 2029-04-24 Ordinary Shares 154 302 D Employee Stock Option (right to buy) 9.82 2024-11-11 4 M 0 1109 0 D 2029-04-24 Ordinary Shares 1109 12954 D This transaction occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2024. This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.28836 to GBP 1.00 as of November 11, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5) and (6). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.08 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.73 to $24.81 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.82 to $24.825 inclusive. This option is fully vested and exercisable. /s/ Jason Minio, Attorney-in-Fact 2024-11-13